Jinhai Medical Technology Ltd. has reported a decline in revenue for the first half of 2025, with figures dropping from S$25.9 million in 1H2024 to S$14.5 million in 1H2025. This represents a significant decrease of 44%. The breakdown of revenue shows that the provision of minimally invasive surgery solutions and medical products and related service fees fell by 48.5%, from S$12.3 million to S$6.3 million. Revenue from manpower outsourcing and ancillary services decreased by 15.5%, from S$7.6 million to S$6.5 million. Additionally, income from dormitory services saw a sharp decline of 75.4%, from S$5.6 million to S$1.4 million. Construction ancillary services remained relatively stable, with a slight decrease of 0.7%, from S$140,000 to S$139,000. The company is considering exploring different ways of raising funds in the capital market in Hong Kong and/or other places as necessary and appropriate, in response to the financial resources required for business development. No further detailed analysis of net income, profit or loss, or earnings per share was provided.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jinhai Medical Technology Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.
Comments